BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 18468953)

  • 1. Medical management of fibroids.
    Sankaran S; Manyonda IT
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review].
    De Falco M; Pollio F; Pontillo M; Ambrosino E; Busiello A; Carbone IF; Ciociola F; Di Nardo MA; Landi L; Di Lieto A
    Minerva Ginecol; 2006 Dec; 58(6):553-60. PubMed ID: 17108883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroids: pathophysiology and current medical treatment.
    Nowak RA
    Baillieres Best Pract Res Clin Obstet Gynaecol; 1999 Jun; 13(2):223-38. PubMed ID: 10755039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GnRH analogues for the treatment of fibroids].
    Murillo EO; Cano A
    Med Clin (Barc); 2013 Jul; 141 Suppl 1():35-9. PubMed ID: 24314566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
    Zeng C; Gu M; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-surgical management of uterine fibroids.
    Tropeano G; Amoroso S; Scambia G
    Hum Reprod Update; 2008; 14(3):259-74. PubMed ID: 18344356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroid growth and medical options for treatment.
    Chabbert-Buffet N; Esber N; Bouchard P
    Fertil Steril; 2014 Sep; 102(3):630-9. PubMed ID: 25171950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine leiomyoma: available medical treatments and new possible therapeutic options.
    Islam MS; Protic O; Giannubilo SR; Toti P; Tranquilli AL; Petraglia F; Castellucci M; Ciarmela P
    J Clin Endocrinol Metab; 2013 Mar; 98(3):921-34. PubMed ID: 23393173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Medical Management for Uterine Leiomyomas.
    Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP; Rymer J; Robinson J; Fogelman I
    Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin-releasing intrauterine systems and leiomyoma.
    Kaunitz AM
    Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
    Cirkel U; Ochs H; Schneider HP; Mettler L; Mayer-Eichberger D; Schindler AE; Bühler K; Winkler U; Zahradnik HP; Künzig HJ
    Clin Ther; 1992; 14 Suppl A():37-50. PubMed ID: 1606593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
    Lethaby A; Vollenhoven B; Sowter M
    BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.